BENZODIAZEPINE WITHDRAWAL SYMPTOMS AND PROPRANOLOL
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
40 patients seen in general practice and psychiatric outpatient clinics who had taken lorazepam or diazepam alone in regular dosage for a mean period of 3.6 years had their benzodiazepine replaced by propranolol (60--120 mg/day) or placebo for two weeks under double-blind conditions. Depending on the criteria for the definition of an abstinence syndrome, 27--45% of the patients had withdrawal symptoms during the study. Propranolol did not affect the drop-out rate or the incidence of withdrawal symptoms but significantly reduced their severity in patients completing the study. The percentage fall in serum levels of desmethyldiazepam in patients who experienced withdrawal symptoms after stopping diazepam was significantly greater in patients with no withdrawal symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, a gradual taper with clonazepam is used as maintenance therapy for BZD-dependent patients.”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [67]
In the citing paper
“However, in the same study, for those with polysubstance abuse, flumazenil did not reduce cravings for other drugs and did not restore BZD receptors’ sensitivity [67].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [67]
In the citing paper
“However, in the same study, for those with polysubstance abuse, flumazenil did not reduce cravings for other drugs and did not restore BZD receptors’ sensitivity [67].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [67]
In the citing paper
“This study was limited by the small sample size, a lack of double-blinding, multiple parallel treatments, and had the potential for subjects to fail to report relapse in drug use [67].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [67]
In the citing paper
“However, it still carries the risk for abuse and dependence since this is also a BZD, albeit a slow-acting one [67].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [67]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Benzodiazepines in Clinical Practice
Shader, R. I., & Greenblatt, D. J. (1974) · Cited by 308
Use of medicines in general practice.
Skegg, D. C., Doll, R., & Perry, J. (1977) · BMJ · doi:10.1136/bmj.1.6076.1561 · Cited by 209
Rebound Insomnia: A New Clinical Syndrome
Kales, A., Scharf, M. B., & Kales, J. D. (1978) · Science · doi:10.1126/science.684426 · Cited by 200
BENZODIAZEPINES: USE, OVERUSE, MISUSE, ABUSE?
(1973) · The Lancet · doi:10.1016/s0140-6736(73)90405-4 · Cited by 165
LENGTH OF TREATMENT WITH ANXIOLYTIC SEDATIVES AND RESPONSE TO THEIR SUDDEN WITHDRAWAL
Covi, L., Lipman, R. S., Pattison, J. H., Derogatis, L. R., & Uhlenhuth, E. H. (1973) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1973.tb04398.x · Cited by 162
Winokur, A. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140103012 · Cited by 156
Systematic review of the benzodiazepines.
Priest, R. G. (1980) · BMJ · doi:10.1136/bmj.280.6221.1085-a · Cited by 93
Abrupt Withdrawal From Therapeutically Administered Diazepam: Report of a Case
Pevnick, J. S. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770320089008 · Cited by 91
Drug treatment of psychiatric patients in general practice.
Tyrer, P. (1978) · BMJ · doi:10.1136/bmj.2.6143.1008 · Cited by 85
Self-citationWITHDRAWAL PSYCHOSIS: A STUDY OF 30 CONSECUTIVE CASES
Fruensgaard, K. (1976) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1976.tb00065.x · Cited by 75
Cited by
Jerram, T. C. (1981) · Side Effects of Drugs Annual · doi:10.1016/s0378-6080(81)80009-8 · Cited by 690
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
“The reported incidence varies between 30 and 100% in different studies, but up to 50% of long-term users decline to participate in, or drop out of, withdrawal studies [ 4 ,34,35].”
BackgroundCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Tyrer, P., & Baldwin, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69865-6 · Cited by 404
Self-citationRickels, K. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290060008 · Cited by 384
Metadata
- Authors
- TYRER, P.
- Affiliations
- New Cross Hospital (GB)
- Corresponding author
- TYRER, P
- ORCID
- TYRER, P
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1981-03
- Volume
- 317
- Issue
- 8219
- Pages
- 520-522
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2071220073
- Cited by
- 297
- References
- 15
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 6 · 2018: 2 · 2015: 2 · 2014: 2 · 2012: 3
- FWCI
- 25.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- benzodiazepine withdrawal, propranolol, lorazepam, diazepam, withdrawal syndrome, desmethyldiazepam, withdrawal symptom severity, beta-adrenergic blockade
- MeSH terms
- Diazepam, Humans, Lorazepam, Placebos, Propranolol, Substance Withdrawal Syndrome, Time Factors, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BENZODIAZEPINE WITHDRAWAL SYMPTOMS AND PROPRANOLOL. https://app.cochat.ai/papers/10.1016/s0140-6736(81)92861-0
- The paper
- TYRER, P. (1981). BENZODIAZEPINE WITHDRAWAL SYMPTOMS AND PROPRANOLOL. The Lancet. https://doi.org/10.1016/s0140-6736(81)92861-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.